NEW YORK ( TheStreet) -- The looming fiscal cliff should have investors seeking safety in high-quality stocks like Pepsi ( PEP) and Varian Medical Systems ( VAR), says Rob McIver, portfolio manager for the Jensen Quality Growth Fund ( JENSX). The $4 billion fund, which garners four stars from fund rater Morningstar, has returned 13% in the past year, outpacing two-thirds of its rivals in the firm's large-cap growth category. Welcome to TheStreet's Fund Manager Five Spot, where top fund managers give their best stock picks and views on the market in a five-question format. What is your view of the economy? McIver: We are optimistic on the long-term outlook for the U.S. economy, but more cautious in the short term. The U.S. unemployment rate has been too high for a robust recovery to take hold and the ongoing Eurozone economic problems remain a significant headwind and the recession in Europe has been a major theme of the third quarter's earning's season. As the looming U.S. fiscal cliff is less than two months away, we favor high-quality growth companies that are able to deliver consistently high returns on equity. We are demanding investors and we'll only invest in a company if it has been able to post a return on equity of at least 15% each year for 10 years. Fewer than 200 US companies meet this hurdle but the average return on equity of our portfolio companies today is over 28%, so despite the challenging economic conditions, these are incredibly profitable businesses. What is your top stock pick? McIver: We are impressed with the long-term business performance delivered by Pepsi, a global market dominator in the snacks and beverage markets. Pepsi accounts for 40% of the worldwide market in salty snacks, making it 10 times larger than its next closest competitor. The company owns 19 brands that generate sales of more than $1 billion per year and the company's daily net income is more than $17 million. Pepsi is heavily focused on growing overseas revenues that now account for nearly 50% of its total and the faster growing emerging markets account for about 31% of sales. We also believe that the management team is stockholder-friendly, returning over $25 billion to shareholders in the form of dividends and share buybacks over the five years ended December 2011, but the share price does not appear expensive to us.